Neopharm Labs Inc., a full-service analytical laboratory serving the pharmaceutical industry, has acquired MS Pharma, a company that specializes in chemical and microbiological quality control analyses.
Jordan-based MS Pharma announces the acquisition of the Greek generic manufacturer Genepharm, aiming to add cardiovascular, CNS and oncology products to its portfolio.
MS Pharma, a fast growing pharmaceutical company based in Jordan and operating across the Middle East, Turkey and Africa, announced today that it has entered into an agreement to acquire 100% of the outstanding shares in Genepharm, a leading European pharmaceutical company. Genepharm's senior management will remain with the business and help guide the company through the next phase of its growth. The transaction is expected to close by the end of April.
Market Place
Share
Share
